Search

Type

Audience

Category

Issue

Last updated

Recall class

Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archived checkbox.

Displaying 1 - 13 of 13 items.

" " NETSPOT: Out of Specification
The Vial 1 assay may be out of specification in the affected lot(s).
RecallHealth product recall | 2022-03-24
" " Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter
UPDATED INFORMATION – May 6, 2022 Further to the communication below, issued on March 15, 2022, regarding the potential for the presence of particulate matter in vials of Sodium Acetate Injection, USP (DIN 02139529) from lot 6126554, Fresenius Kabi…
AlertHealth professional risk communication | 2022-03-15
" " Maximum Strength Acid Reducer Without prescription: NDMA impurity
Presence of N-nitrosodimethylamine (NDMA) close or above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-03-11
" " Ranitidine products recalled because of a nitrosamine impurity
UPDATE: March 11, 2022 – Pharmascience Inc. recalls 30 lots of 150 mg over-the-counter ranitidine packaged in blister packs Pharmascience Inc. is recalling 30 lots of over-the-counter ranitidine drugs (150 mg tablets), packaged in blister packs, after…
AlertInformation update | 2022-03-11
" " Anticipated shortage of euthanasia products for animals
UPDATED INFORMATION – March 10, 2022 Further to the Health Canada communication below, issued on June 15, 2021, while initial estimates of supply and demand forecasted that the global shortage could impact Canada’s supply in early 2022, careful…
AlertHealth professional risk communication | 2022-03-10
" " 0.9% Sodium Chloride Injection, USP and Lactated Ringer’s Injection, USP - Potential Leak During Pressure Infusion
Intravenous bags of Baxter’s 0.9% Sodium Chloride Injection, USP 500 mL and Lactated Ringer’s Injection, USP 500 mL from certain lots have the potential to leak when administered under pressure infusion due to a weak seal formation. Affected lots are…
AlertHealth professional risk communication | 2022-03-09
" " Phytonadione USP: Unspecified impurities are out of specification
Unspecified impurities are out of specification in the affected lot.
RecallHealth product recall | 2022-03-08
" " Heparin Sodium and 0.9% Sodium Chloride Injection: leak in intravenous bag
Intravenous bag may be leaking in affected lot
RecallHealth product recall | 2022-03-07
" " Sodium Acetate Injection, USP: Particulate matter
Presence of particulate matter in affected lots.
RecallHealth product recall | 2022-03-07
" " Accuretic (quinapril hydrochloride and hydrochlorothiazide): Nitrosamine Impurity
 Presence of impurity N-Nitroso-quinapril above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-03-04
" " Teva-Ectosone: product quality
 The product lots may not meet product specification at end of shelf life.
RecallHealth product recall | 2022-03-02
" " Inderal-LA: Nitrosamine Impurity
 Presence of impurity N-Nitroso-propanolol above the acceptable concentration limit in affected lots.
RecallHealth product recall | 2022-03-02
" " Pfizer recalls Inderal-LA (propranolol hydrochloride) capsules due to a nitrosamine impurity
Pfizer Canada ULC is recalling all lots of Inderal-LA (propranolol hydrochloride) extended release capsules, in 60 mg, 80 mg, 120 mg and 160 mg strengths, due to the presence of a nitrosamine impurity (N-nitroso-propranolol) above the acceptable level…
AlertPublic advisory | 2022-03-01
Report a problem or mistake on this page
What was wrong?

If you want to receive a follow-up reply, please include your name and e-mail address.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.